Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 3, keine Gesamtzahl für „sulphate“
Suchtreffer
Begriffe & Kennungen
Clopidogrel Teva (hydrogen sulphate) · 4.5 · Rosuvastatin: Clopidogrel has been shown to increase rosuvastatin exposure in patients by 2-fold (AUC) and 1.3
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · SSRIs: since SSRIs affect platelet activation and increase the risk of bleeding, the concomitant administratio
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · The pharmacokinetics of digoxin or theophylline were not modified by the co-administration of clopidogrel. Ant
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · There is no evidence that other medicinal products that reduce stomach acid such as H2 blockers or antacids in
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.5 · Thrombolytics: the safety of the concomitant administration of clopidogrel, fibrin or non-fibrin specific thro
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.6 Fertility, pregnancy and lactation · 1
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 Undesirable effects · 1
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · * Information related to clopidogrel with frequency “not known”.
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · 11 System Organ Common Uncommon Rare Very rare, not Class known*
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · 12 System Organ Common Uncommon Rare Very rare, not Class known*
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · 9 In COMMIT, the overall rate of noncerebral major bleeding or cerebral bleeding was low and similar in both g
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · Adverse reactions that occurred either during clinical studies or that were spontaneously reported are present
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · Bleeding is the most common reaction reported both in clinical studies as well as in post-marketing experience
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · Blood and the Thrombocytopenia, Neutropenia, Thrombotic lymphatic leucopenia, including thrombocytopenic syste
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · Clopidogrel has been evaluated for safety in more than 44,000 patients who have participated in clinical studi
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · Gastrointestinal Gastrointestinal Gastric ulcer and Retroperitoneal Gastrointestinal and disorders hemorrhage,
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · General Bleeding at Fever disorders and puncture site administration site conditions
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · Hepato-biliary Acute liver failure, disorders hepatitis, abnormal liver function test
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · In ACTIVE-A, the rate of major bleeding was greater in the clopidogrel + ASA group than in the placebo + ASA g
Eintrag öffnenClopidogrel Teva (hydrogen sulphate) · 4.8 · In CAPRIE, in patients treated with either clopidogrel or ASA, the overall incidence of any bleeding was 9.3%.
Eintrag öffnen